Monoclonal Antibodies: Streamlined Nonclinical Safety Studies: Draft Guidance for Industry - FDA Guidance Document

Monoclonal Antibodies: Streamlined Nonclinical Safety Studies: Draft Guidance for Industry - FDA Guidance Document | Global Key Solutions